Circulating Markers in Preterm Infants With Perinatal and Neonatal Inflammation
NCT ID: NCT03320785
Last Updated: 2022-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
50 participants
OBSERVATIONAL
2017-09-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors of Sepsis in Ex-Preterm Infants
NCT03433846
Intestinal Perfusion After Feeding in Preterm and Term Infants
NCT06319326
Defining the Intestinal Microbiota in Premature Neonates
NCT01102738
Long Term Health Cohort of Premature Infants
NCT05017389
Neurodevelopmental Outcomes of Preterm and Term Children
NCT02309697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary objective: To characterize circulating markers associated with the early life complications including chorioamnionitis, LOS and NEC in preterm infants during the first four weeks of life.
Secondary objective: To characterize how different feeding regimes and diets may affect these markers during the first four weeks of life in preterm infants
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed parental consent
Exclusion Criteria
1 Day
1 Day
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baoan Maternal And Child Health Care Hospital, Shenzhen, China
UNKNOWN
Per Torp Sangild
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Per Torp Sangild
Professor, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Per T Sangild, PhD
Role: STUDY_DIRECTOR
Rigshospitalet, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shenzheng Baoan Maternity and Child Healthcare Hospital (SBMCH)
Shenzhen, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Related Links
Access external resources that provide additional context or updates about the study.
The current clinical trial is a part of the NEOMUNE project.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NEOINFLAM 2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.